74 Results for "

PKG

" in MedChemExpress (MCE) Product Catalog:
Products (74)

74 Results for "PKG" in MCE Product Catalog:

  • Targets Recommended:
  • Recombinant Proteins Recommended:
192
192 Publications Verification
Cat. No.: HY-15979
CAS No.: 127243-85-0
Target:  

PKA Autophagy

Research Areas:  

Neurological Disease

H-89 is a potent and selective inhibitor of cyclic AMP-dependent protein kinase (protein kinase A) with IC50 of 48 nM and has weak inhibition on PKG, PKC, Casein Kinase, and others kinases.
loading...
    loading...
192
192 Publications Verification
Cat. No.: HY-15979A
CAS No.: 130964-39-5
Target:  

PKA Autophagy

Research Areas:  

Others

H-89 dihydrochloride is a potent and selective inhibitor of protein kinase A (PKA) with an IC50 of 48 nM and has weak inhibition on PKG, PKC, Casein Kinase.
loading...
    loading...
29
29 Cited Publications
Cat. No.: HY-10341
CAS No.: 105628-07-7
Purity:  99.97%
Synonyms: HA-1077 Hydrochloride; AT-877 Hydrochloride
Research Areas:  

Cancer

Fasudil (HA-1077; AT877) Hydrochloride is a nonspecific RhoA/ROCK inhibitor and also has inhibitory effect on protein kinases, with an Ki of 0.33 μM for ROCK1, IC50s of 0.158 μM and 4.58 μM, 12.30 μM, 1.650 μM for ROCK2 and PKA, PKC, PKG, respectively. Fasudil Hydrochloride is also a potent Ca 2+ channel antagonist and vasodilator .
loading...
    loading...
29
29 Cited Publications
Cat. No.: HY-10341A
CAS No.: 103745-39-7
Synonyms: HA-1077; AT877
Research Areas:  

Cancer

Fasudil (HA-1077; AT877) is a nonspecific RhoA/ROCK inhibitor and also has inhibitory effect on protein kinases, with an Ki of 0.33 μM for ROCK1, IC50s of 0.158 μM and 4.58 μM, 12.30 μM, 1.650 μM for ROCK2 and PKA, PKC, PKG, respectively. Fasudil is also a potent Ca 2+ channel antagonist and vasodilator .
loading...
    loading...
29
29 Cited Publications
Cat. No.: HY-10341C
CAS No.: 203911-27-7
Synonyms: HA-1077 dihydrochloride; AT-877 dihydrochloride
Research Areas:  

Cancer

Fasudil (HA-1077; AT877) dihydrochloride is a nonspecific RhoA/ROCK inhibitor and also has inhibitory effect on protein kinases, with an Ki of 0.33 μM for ROCK1, IC50s of 0.158 μM and 4.58 μM, 12.30 μM, 1.650 μM for ROCK2 and PKA, PKC, PKG, respectively. Fasudil dihydrochloride is also a potent Ca 2+ channel antagonist and vasodilator .
loading...
    loading...
13
13 Cited Publications
Cat. No.: HY-N6791
CAS No.: 126643-37-6
KT5823, a selective the cGMP-dependent protein kinase (PKG) inhibitor with an Ki value of 0.23 μM, it also inhibits PKA and PKC with Ki values of 10 μM and 4 μM, respectively. KT5823 is a Staurosporine-related protein kinase inhibitor, increases thyroid-stimulating hormone-induced (Na +/I - symporter) NIS expression, and iodide uptake in thyroid cells. KT5823 arrests cells after the G0/G1 boundary and causes increases in the levels of apoptotic DNA fragmentation .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-101379A
CAS No.: 51116-01-9
Purity:  99.81%
8-Bromo-cGMP sodium, a membrane-permeable analogue of cGMP, is a PKG (protein kinase G) activator. 8-Bromo-cGMP sodium significantly inhibits Ca 2+ macroscopic currents and impairs insulin release stimulated with high K + . 8-Bromo-cGMP sodium has antinociceptive effects and results in vasodilator responses .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P1292
CAS No.: 82801-73-8
Target:  

PKG

Research Areas:  

Cancer

PKG inhibitor peptide is an ATP-competitive inhibitor of cGMP-dependent protein kinase (PKG), with a Ki of 86 μM .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P2692B
Target:  

PKG

Research Areas:  

Cancer

DT-2 is a potent and selective inhibitor of the cGMP-dependent protein kinase (PKG). DT-2 inhibits PKG catalyzed phosphorylation (Ki: 12.5 nM) .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-112197
CAS No.: 374703-78-3
Purity:  99.11%
Target:  

PKG

Research Areas:  

Cardiovascular Disease

PKG agent G1 targets C42 of PKG. PKG agent G1 can couple to vasodilation and blood pressure lowering by a C42 PKG Iα-independent mechanism.
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-130354
CAS No.: 51116-00-8
Purity:  99.55%
Synonyms: Bt2cGMP sodium
Target:  

Potassium Channel

Research Areas:  

Cardiovascular Disease

Dibutyryl-cGMP sodium (Bt2cGMP sodium) is a cell-permeable cGMP analogue. Dibutyryl-cGMP sodium preferentially activates cGMP-dependent protein kinase (PKG). Dibutyryl-cGMP sodium inhibits the release of [ 3H]-arachidonic acid from γ thrombin-stimulated human platelets. Dibutyryl-cGMP sodium induces peripheral antinociception via activation of ATP-sensitive K + channels .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-18252
CAS No.: 330784-47-9
Synonyms: TA1790
Avanafil (TA-1790) is a potent and selective phosphodiesterase-5 (PDE-5) inhibitor with IC50 values of 5.2 nM, 630 nM, 5700 nM, 6200 nM, 12000 nM, 27000 nM, 51000 nM and 53000 nM for PDE-5, PDE-6, PDE-4, PDE-10, PDE-8, PDE-7, PDE-2 and PDE-1, respectively. Avanafil activates NO/cGMP/PKG signaling-pathway to decrease loss in BMD, bone atrophy, and oxidative stress. Avanafil inhibits cyclic guanosine monophosphate (cGMP) hydrolysis and thus increases cGMP levels. Avanafil can be used for the research of erectile dysfunction and osteoporosis .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-100984
CAS No.: 84468-24-6
Purity:  99.87%
Target:  

PKA PKC Myosin ROCK

Research Areas:  

Cancer

HA-100 is a potent protein kinase inhibitor, with IC50s of 4 μM, 8 μM, 12 μM and 240 μM for cGMP-dependent protein kinase (PKG), cAMP-dependent protein kinase (PKA), protein kinase C (PKC) and MLC-kinase, respectively. HA-100 also used as a ROCK inhibitor .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-113469
CAS No.: 7665-99-8
Purity:  99.43%
Cyclic GMP (cGMP), an important second messenger, is a major intracellular mediator of extracellular signals such as nitric oxide (NO) and natriuretic peptides (NPs). Effects of Cyclic GMP occur through three main groups of cellular targets: cGMP-dependent protein kinases (PKGs), cGMP-gated cation channels, and PDEs. Cyclic GMP can inhibit both platelet adhesion and aggregation. cGAMP (Cyclic-GMP-AMP) (HY-12512), a conjugate of Cyclic GMP and AMP, can induce IRF3 phosphorylation and nuclear translocation, enhancing antiviral immune responses .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-113469A
CAS No.: 40732-48-7
Purity:  99.89%
Cyclic GMP (cGMP) sodium, an important second messenger, is a major intracellular mediator of extracellular signals such as nitric oxide (NO) and natriuretic peptides (NPs). Effects of Cyclic GMP sodium occur through three main groups of cellular targets: cGMP-dependent protein kinases (PKGs), cGMP-gated cation channels, and PDEs. Cyclic GMP can inhibit both platelet adhesion and aggregation. cGAMP (Cyclic-GMP-AMP) (HY-12512), a conjugate of Cyclic GMP and AMP, can induce IRF3 phosphorylation and nuclear translocation, enhancing antiviral immune responses .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-135110
CAS No.: 208445-06-1
Synonyms: Rp-8-bromo-Cyclic GMPS sodium
Research Areas:  

Metabolic Disease

Rp-8-Br-cGMPS (Rp-8-bromo-Cyclic GMPS) sodium salt is a potent Ca 2+-ATPase activator. Rp-8-Br-cGMPS is also an agonist of the rod CNG channel and an inhibitor of PKG. Rp-8-Br-cGMPS sodium salt mediates cytosolic Ca 2+ reduction by activating Ca 2+-ATPase and subsequently removing Ca 2+ from the cell .
loading...
    loading...
Cat. No.: HY-15720B
CAS No.: 913844-45-8
Target:  

ROCK Aurora Kinase CaMK

Research Areas:  

Neurological Disease

Glycyl H-1152 hydrochloride (compound 18) is a glycyl derivative of Rho-kinase inhibitors H-1152 dihydrochloride. Glycyl H-1152 hydrochloride inhibits ROCKII, Aurora A, CAMKII and PKG, with IC50s of 0.0118, 2.35, 2.57 and 3.26 μM respectively. Glycyl H-1152 hydrochloride has higher selective than H-1152 hydrochloride .
loading...
    loading...
Cat. No.: HY-P0142A
Target:  

PKG

Research Areas:  

Cardiovascular Disease

DT-3 acetate is a membrane-permeable protein kinase G Iα (PKG Iα) inhibitory peptide and shows pharmacological blockade of the cGMP-PKG signalling .
loading...
    loading...
Cat. No.: HY-137325A
CAS No.: 301334-89-4
Target:  

Calcium Channel

Research Areas:  

Metabolic Disease

2-Chloro-ATP sodium (2-Chloro ATP) is an adenine nucleotide and an analog of ATP. It is an antagonist of the purinergic P2Y1 receptor and inhibits intracellular calcium mobilization induced by ADP (HY-W010918) in Jurkat cells expressing the human receptor (Ki=2.3 μM). 2-Chloro-ATP sodium is an agonist of the purinergic P2X receptor and induces inward currents in HEK293 cells expressing human bladder smooth muscle or rat PC12 forms of the receptor (EC50=0.5 and 2.5 μM). 2-Chloro-ATP sodium induces relaxation of precontracted guinea pig cecal strips in a concentration-dependent manner. 2-Chloro-ATP sodium has been used to study the substrate specificity of cyclic nucleotide-dependent protein kinases such as protein kinase A (PKA) and PKG.
loading...
    loading...
Cat. No.: HY-134345
CAS No.: 272445-72-4
Synonyms: 8-(4-Chlorophenylthio)-cGMP-AM
Target:  

PKG

Research Areas:  

Neurological Disease

8-pCPT-cGMP-AM (8-(4-Chlorophenylthio)-cGMP-AM) is a highly membrane permeable prodrug of the PKG agonist 8-pCPT-cGMP, which increases the membrane permeability of cGMP and is converted to its active form by esterase hydrolysis within the cell, thereby activating PKG. 8-pCPT-cGMP-AM can be used to explore the role of cGMP signaling in neural plasticity and memory formation .
loading...
    loading...